Skip to main content
. 2019 Aug 6;20(4):3317–3325. doi: 10.3892/mmr.2019.10562

Figure 1.

Figure 1.

Detection of the expression levels of EGFR and E-cadherin in HCC tumor samples. (A) Reverse transcription-quantitative PCR and (B) western blot analysis of EGFR and E-cadherin. (C) Densitometric analysis of the protein expression levels of EGFR and E-cadherin. n=42. *P<0.05, **P<0.01. EGFR, epidermal growth factor receptor; TAE, transcatheter arterial embolization; HCC, hepatocellular carcinoma.